The COVID-19 pandemic disproportionately disrupts the daily lives of marginalized populations.
Persons with substance use disorders are a particularly vulnerable population because …

Purpose of Review The COVID-19 pandemic is associated with increased levels of stress,
anxiety and depression in the population. These are associated with unhealthy eating …

COVID-19 can worsen the physical health of individuals with serious mental illness, a
vulnerable group already facing physical health disparities. COVID-19 is further reducing access …

Objective To assess the level of anticoagulation control achieved in patients with atrial
fibrillation (AF) receiving routine medical care within a large managed care organization and to …

Background Smoking continues to be a leading cause of preventable chronic disease-related
morbidity and mortality, excess healthcare expenditure, and lost work productivity. …

Objective: Individuals with severe mental illness (SMI) are disproportionally affected by medical
comorbidities, resulting in poor physical health and premature death. Despite this, care …

Background: For individuals living with diabetes and its psychosocial comorbidities (eg,
depression, anxiety, and distress), there remains limited access to interprofessional, integrated …

The coronavirus disease 2019 (COVID-19) pandemic and the resulting societal response to
limit its spread poses a threat to vulnerable groups such as those with substance use …

Objective: Antipsychotic use is associated with elevated cardiometabolic risk. Guidelines for
metabolic risk screening of individuals taking antipsychotics have been issued, but with little …

Background: Given the harms associated with tobacco use, continuing the provision of smoking
cessation treatment during the COVID-19 pandemic is critical. The aim of this study was …